1 study found for:    22432104 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Device: Pen auto-injector

Indicates status has not been verified in more than two years